Cite
Hwang GE, Lee JW, Jeon S, et al. Vogt-Koyanagi-Harada syndrome-like uveitis after nivolumab administration as a treatment for ovarian cancer. Doc Ophthalmol. 2022;doi: 10.1007/s10633-021-09862-8.
Hwang, G. E., Lee, J. W., Jeon, S., Cho, I. H., & Kim, H. D. (2022). Vogt-Koyanagi-Harada syndrome-like uveitis after nivolumab administration as a treatment for ovarian cancer. Documenta ophthalmologica. Advances in ophthalmology, . https://doi.org/10.1007/s10633-021-09862-8
Hwang, Gyu Eun, et al. "Vogt-Koyanagi-Harada syndrome-like uveitis after nivolumab administration as a treatment for ovarian cancer." Documenta ophthalmologica. Advances in ophthalmology vol. (2022). doi: https://doi.org/10.1007/s10633-021-09862-8
Hwang GE, Lee JW, Jeon S, Cho IH, Kim HD. Vogt-Koyanagi-Harada syndrome-like uveitis after nivolumab administration as a treatment for ovarian cancer. Doc Ophthalmol. 2022 Jan 08; doi: 10.1007/s10633-021-09862-8. Epub 2022 Jan 08. PMID: 34997406.
Copy
Download .nbib